Intellia Therapeutics, Inc.
NTLA
$11.91
$0.080.68%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 437.76M | 375.99M | 449.88M | 511.04M | 459.65M |
| Total Receivables | 7.32M | 9.13M | 9.47M | 11.05M | 11.35M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 82.75M | 81.33M | 68.36M | 59.67M | 24.94M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 177.00K | -- |
| Total Current Assets | 527.83M | 466.45M | 527.71M | 581.94M | 495.95M |
|
|
|||||
| Total Current Assets | 527.83M | 466.45M | 527.71M | 581.94M | 495.95M |
| Net Property, Plant & Equipment | 101.01M | 113.06M | 123.63M | 138.30M | 151.85M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 15.84M | 16.46M | 13.08M | 16.69M | 54.16M |
| Total Assets | 857.16M | 758.78M | 842.13M | 925.28M | 898.89M |
|
|
|||||
| Total Accounts Payable | 11.71M | 18.80M | 20.25M | 13.26M | 9.80M |
| Total Accrued Expenses | 44.33M | 37.92M | 49.86M | 40.84M | 41.55M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 23.34M | 19.10M | 26.48M | 27.38M | 26.99M |
| Total Finance Division Other Current Liabilities | -- | 630.00K | 7.29M | 12.25M | 17.15M |
| Total Other Current Liabilities | -- | 630.00K | 7.29M | 12.25M | 17.15M |
| Total Current Liabilities | 79.39M | 76.45M | 103.88M | 93.73M | 95.50M |
|
|
|||||
| Total Current Liabilities | 79.39M | 76.45M | 103.88M | 93.73M | 95.50M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 50.07M | 61.40M | 66.85M | 70.59M | 75.60M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 12.54M | 12.54M |
| Total Liabilities | 129.46M | 137.84M | 170.73M | 176.85M | 183.64M |
|
|
|||||
| Common Stock & APIC | 3.52B | 3.31B | 3.26B | 3.24B | 3.11B |
| Retained Earnings | -2.79B | -2.69B | -2.59B | -2.49B | -2.39B |
| Treasury Stock & Other | -1.03M | -240.00K | 1.03M | 990.00K | 653.00K |
| Total Common Equity | 727.71M | 620.94M | 671.39M | 748.42M | 715.26M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 727.71M | 620.94M | 671.39M | 748.42M | 715.26M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 727.71M | 620.94M | 671.39M | 748.42M | 715.26M |
|
|
|||||